Titration of Intraoperative PEEP in Patients Undergoing Robotic Assisted Laparoscopic Prostatectomy
TIPPR
Titration of Intraoperative Positive End-expiratory Pressure to Optimize Gas Exchange in Patients Undergoing Robotic Assisted Laparoscopic Prostatectomy
1 other identifier
interventional
95
1 country
2
Brief Summary
Optimal intraoperative positive end expiratory pressure (PEEP) improves the outcome. Optimal PEEP is not only very different among individuals, but each individual's optimal PEEP is affected by positioning, muscle paralysis, and several other factors. Several techniques have been used to determine the optimal PEEP. For example, electrical impedance tomography(EIT)can be performed at the bedside.However, the application of this technique requires special training, increases the workload of the care team, and the cost-efficiencyof this procedure remains to be determined.We hypothesized that optimal PEEP could be obtained by titration of intraoperative PEEP levels and FiO2with SpO2 guidance. Our secondary hypothesis was that maintenance of intraoperative optimal PEEP derived via this method improves intraoperative oxygenation and reduces the incidence of postoperative hypoxemia.We tested our hypothesis in patients undergoing robotic-assisted laparoscopic prostatectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 20, 2021
CompletedFirst Submitted
Initial submission to the registry
November 18, 2021
CompletedFirst Posted
Study publicly available on registry
December 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2023
CompletedFebruary 15, 2023
February 1, 2023
1.1 years
November 18, 2021
February 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The difference of optimal PEEP titrated by two methods
Titration result of the two groups
within 30 minutes after trachea intubation
Secondary Outcomes (4)
Difference of intraoperative PaO2/FiO2 between the two groups
30,60,120 minutes after finishing PEEP titration
Difference of intraoperative driving pressure, dynamic compliance between the two groups
30,60,120 minutes after finishing PEEP titration
Difference of lung regional ventilation between the two groups
5 minutes after trachea extubation
Post operation hypoxemia in PACU.
within 30 minutes after trachea extubation
Study Arms (2)
Optimal Positive End-expiratory Pressure obtained with Titration of Fraction of Inspiratory Oxygen
EXPERIMENTALObtained Optimal Positive End-expiratory Pressure obtained with Titration of Fraction of Inspiratory Oxygen and sustained the PEEP intraoperatively
Optimal Positive End-expiratory Pressure obtained with electrical impedance tomography
EXPERIMENTALObtained Optimal Positive End-expiratory Pressure obtained with EIT and sustained the PEEP intraoperatively
Interventions
Titration of Optimal Positive End-expiratory Pressure with two different methods
Eligibility Criteria
You may qualify if:
- adult patients aged 18 years or older
- scheduled for elective robotic-assisted laparoscopic prostatectomy(RALP)
- ASA physical status of I-III
You may not qualify if:
- acute or chronic respiratory disorders
- pulmonary hypertension
- neuromuscular disease
- preoperative SpO2\<95% on room air
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (2)
270 Dongan Road, Fudan University Shanghai Cancer Center
Shanghai, 200032, China
Fudan University Shanghai Cancer Center
Shanghai, China
Study Officials
- STUDY CHAIR
Jun Zhang, PhD
Department of Anesthesiology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Anesthesiology, Fudan University Shanghai Cancer Center
Study Record Dates
First Submitted
November 18, 2021
First Posted
December 13, 2021
Study Start
October 20, 2021
Primary Completion
December 8, 2022
Study Completion
January 20, 2023
Last Updated
February 15, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share